No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs499952 |
chr11:94182992-94182993 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs553287267 |
chr11:94183000-94183001 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs560420754 |
chr11:94183023-94183024 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs147414791 |
chr11:94183080-94183081 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs538869251 |
chr11:94183102-94183103 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs522596 |
chr11:94183148-94183149 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
7 |
rs575552103 |
chr11:94183175-94183176 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs76411833 |
chr11:94183195-94183196 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs569426310 |
chr11:94183199-94183200 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs145158453 |
chr11:94183203-94183204 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs369416822 |
chr11:94183242-94183243 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs187503741 |
chr11:94183317-94183318 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs551888953 |
chr11:94183345-94183346 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs191282786 |
chr11:94183373-94183374 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs77891285 |
chr11:94183399-94183400 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs533105843 |
chr11:94183451-94183452 |
Weak transcription Enhancers Strong transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs544899325 |
chr11:94183466-94183467 |
Weak transcription Enhancers Strong transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs143963226 |
chr11:94183475-94183476 |
Weak transcription Enhancers Strong transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs111628013 |
chr11:94183476-94183477 |
Weak transcription Enhancers Strong transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs548978624 |
chr11:94183505-94183506 |
Weak transcription Enhancers Strong transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs370769414 |
chr11:94183629-94183630 |
Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs560913783 |
chr11:94183649-94183650 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs369381695 |
chr11:94183705-94183706 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs528164283 |
chr11:94183723-94183724 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs546632935 |
chr11:94183782-94183783 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs7119572 |
chr11:94183807-94183808 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
27 |
rs374342832 |
chr11:94183828-94183829 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs562162291 |
chr11:94183834-94183835 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs201642494 |
chr11:94183864-94183865 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs148628602 |
chr11:94183877-94183878 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs372731403 |
chr11:94183885-94183886 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs142066128 |
chr11:94183908-94183909 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs113220421 |
chr11:94183920-94183921 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs2509942 |
chr11:94183940-94183941 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs184543472 |
chr11:94184026-94184027 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs554893797 |
chr11:94184032-94184033 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs141475747 |
chr11:94184070-94184071 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs554535714 |
chr11:94184073-94184074 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs143890311 |
chr11:94184088-94184089 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs533947304 |
chr11:94184139-94184140 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs558984729 |
chr11:94184144-94184145 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs577282477 |
chr11:94184146-94184147 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs59302226 |
chr11:94184201-94184202 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs66655623 |
chr11:94184202-94184203 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs372804708 |
chr11:94184230-94184231 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs545172649 |
chr11:94184253-94184254 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs563503922 |
chr11:94184254-94184255 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs375809790 |
chr11:94184276-94184277 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs537260901 |
chr11:94184278-94184279 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs557465074 |
chr11:94184287-94184288 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|